AA Contact info

Tracy Benning
Phone: 919.821.6654
Fax: 919.821.6800

Practice Areas

Bar & Court Admissions

  • North Carolina
  • Pennsylvania


Emory University, J.D., 1989

Columbia University, A.B., 1984

Find Professionals
Photo of Michael P. Saber

Michael P. Saber

  • 150 Fayetteville Street, Suite 2300
    Raleigh, North Carolina 27601
  • Phone: 919.821.6772
  • Fax: 919.821.6800

Mike Saber represents clients in a variety of corporate activities, including venture capital transactions, mergers and acquisitions, commercial contracts, capital-raising and technology transactions and strategic collaborations.  He aids in the growth and development of businesses by becoming a part of their deal teams, working with management, boards of directors and other advisors.

Mike practiced corporate law for seven years at Blank Rome, LLP in Philadelphia before he joined Smith Anderson in 1996.

Professional & Community Affiliations

  • Council for Entrepreneurial Development (CED)
    • Board of Directors (2015-Present)
  • North Carolina Bar Association
  • Wake County Bar Association
  • Past Director, Association for Corporate Growth, RTP Chapter
  • Founding Director, National Association of Corporate Directors, RTP Chapter
  • Past President, Temple Beth Or, Raleigh, NC

Honors & Awards

  • "Lawyer of the Year," Biotechnology Law, in Raleigh by The Best Lawyers in America© (2015)
  • The Best Lawyers in America©, Biotechnology Law; Corporate Law; Mergers & Acquisitions Law; Securities/Capital Markets Law; Venture Capital Law (2010-2017)
  • Business North Carolina Legal Elite 
  • Martindale-Hubbell AV Preeminent Rated 
  • North Carolina Super Lawyers (2011-2016)


  • Lead counsel to a venture capital-funded genome editing company in a worldwide partnership, worth up to $1.6 billion, including an upfront payment of $105 million, with a global, publicly-traded pharmaceutical company to develop and commercialize allogeneic chimeric antigen receptor (CAR) T cell therapies for multiple cancers.
  • Represented a private ag biotech company in a $400 million sale to public ag bio company in a cash and milestone-based transaction
  • Represented second and third generation owners in sale of their interests in family-owned industrial company in structured finance transaction
  • Represented a drug development company in $60 million late stage venture capital raising preferred stock financing (largest such deal in the Southeast at the time)
  • Represented the special board committee of portfolio company of large private equity fund in connection with financing transaction
  • Represents institutional investors in portfolio company financings, including seed financings of technology, life sciences and ag biotech companies 
  • Represented a healthcare IT company in connection with $100 million bid for strategic target in auction process and in multiple other acquisitions
  • Represents a manufacturer dealer network in strategic acquisitions for cash and stock of family-owned businesses for expansion and consolidation of network
  • Represented a large contract research organization in strategic acquisition of global consulting firm
  • Represents ESOP companies and trustees in sell-side and buy-side transactions



  • Contributor, “Middle Market M&A: Handbook for Investment Banking and Business Consulting,” Wiley Finance, 2012